<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0904233509
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2010
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        AMLOCARD 5MG TABLETS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        AMLODIPINE BESILATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        26.45
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="BATTERJEE PHARMACETICAL FACTORY" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            BATTERJEE PHARMACETICAL FACTORY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 651]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            BATTERJEE PHARMACEUTICAL FACTORY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            BATTERJEE PHARMACETICAL FACTORY
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C08CA01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>It contains the active substance amlodipine which belongs to a group of medicines called.</p><p>It is used to:treat high blood pressure (hypertension) or a certain type of chest pain called angina, a rare form of which is Prinzmetal&rsquo;s or variant angina.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;In patients with high blood pressure this medicine works by relaxing blood vessels, so that blood passes through them more easily. In patients with angina AMLOCARD&reg; 5mg works by improving blood supply to the heart muscle which then receives more oxygen and as a result chest pain is prevented. This medicine does not provide immediate relief of chest pain from angina.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take AMLOCARD&reg; 5mg:</p><p>- If you are allergic (hypersensitive) to amlodipine, or any of the other ingredients of this medicine listed in section 6, or to any other calcium antagonists. This allergic reactions may be itching, reddening of the skin or difficulty in breathing.</p><p>- If you have severe low blood pressure (hypotension).</p><p>- If you have narrowing of the aortic heart valve (aortic stenosis) or cardiogenic shock (a condition where your heart is unable to supply enough blood to the body).</p><p>- If you suffer from heart failure after a heart attack.</p><p>&nbsp;</p><p>Warnings and precautions</p><p>Talk to your doctor or pharmacist before taking it.</p><p>You should inform your doctor if you have or have had any of the following conditions:</p><p>- Recent heart attack.</p><p>- Heart failure.</p><p>- Severe increase in blood pressure (Hypertensive crisis).</p><p>- Liver disease.</p><p>- You are elderly and your dose needs to be increased.</p><p>&nbsp;</p><p>Children and adolescents</p><p>Amlodipine has not been studied in children under the age of 6 years.</p><p>AMLOCARD&reg; 5mg should only be used for hypertension in children and adolescents from 6 years to 17 years of age (see section 3).For more information, talk to your doctor.</p><p>&nbsp;</p><p>Other medicines and AMLOCARD&reg; 5mg</p><p>Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. may affect or be affected by other medicines, such as:</p><p>- Ketoconazole, itraconazole (anti-fungal medicines).</p><p>- Ritonavir, indinavir, nelfinavir (so called protease inhibitors used to treat HIV).</p><p>- Rifampicin, erythromycin, clarithromycin (antibiotics).</p><p>- Hypericum perforatum (St. John&rsquo;s Wort).</p><p>- Verapamil, diltiazem (heart medicines).</p><p>- Dantrolene (infusion for severe body temperature abnormalities).</p><p>- Tacrolimus (medicine used to alter the way your immune system works).</p><p>- Simvastatin (cholesterol lowering medicine).</p><p>- Cyclosporine (an immunosuppressant).may lower your blood pressure even more if you are already taking other medicines to treat your high blood pressure.</p><p>&nbsp;</p><p>AMLOCARD&reg; 5mg with food &amp; drink</p><p>Grapefruit juice and grapefruit should not be consumed by people who are taking it. This is because grapefruit and grapefruit juice can lead to an increase in the blood levels of the active ingredient amlodipine, which can cause an unpredictable increase in the blood pressure lowering effect.</p><p>&nbsp;</p><p>Pregnancy and breast-feedingPregnancy:</p><p>The safety of amlodipine in human pregnancy has not been established. If you think you might be pregnant, or are planning to get pregnant, you must tell your doctor before you take it.</p><p>&nbsp;</p><p>Breast-feeding:</p><p>It is not known whether amlodipine is passed into breast milk. If you are breast- feeding or about to start breast-feeding you must tell your doctor before taking it.</p><p>&nbsp;</p><p>Driving and using machinesmay affect your ability to drive or use machines. If the tablets make you feel sick, dizzy or tired, or give you a headache, do not drive or use machines and contact your doctor immediately.</p><p>&nbsp;</p><p>Contains sodium</p><p>This medicine contains less than 1 mmol sodium (23 mg) per tablet, which means it is essentially &lsquo;sodium-free&rsquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The recommended initial dose is it once daily. The dose can be increased to 10 mg once daily.</p><p>This medicine can be used before or after food and drinks. You should take this medicine at the same time each day with a drink of water. Do not take it with grapefruit juice.</p><p>&nbsp;</p><p>Use in children and adolescentsFor children and adolescents (6-17 years old),</p><p>the recommended usual starting dose is 2.5 mg a day. The maximum recommended dose is 5 mg a day. The tablets can be divided into halves to provide a 2.5 mg dose.It is important to keep taking the tablets. Do not wait until your tablets are finished before seeing your doctor.</p><p>&nbsp;</p><p>If you take more than you should</p><p>Taking too many tablets may cause your blood pressure to become low or even dangerously low. You may feel dizzy, lightheaded, faint or weak. If blood pressure drop is severe enough shock can occur. Your skin could feel cool and clammy and you could lose consciousness. Seek immediate medical attention if you take too many Amlocard tablets.If you forget to take itDo not worry.</p><p>&nbsp;</p><p>If you forget to take a tablet, leave out that dose completely.</p><p>Take your next dose at the right time. Do not take a double dose to make up for a forgotten dose.</p><p>&nbsp;</p><p>If you stop taking it Your doctor will advise you how long to take this medicine.</p><p>Your condition may return if you stop using this medicine before you are advised.</p><p>If you have any further questions on the use of this medicine, ask your doctor.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. Visit your doctor immediately if you experience any of the following side effects after taking this medicine.</p><p>- Sudden wheeziness, chest pain, shortness of breath or difficulty in breathing.</p><p>- Swelling of eyelids, face or lips.</p><p>- Swelling of the tongue and throat which causes great difficulty breathing.</p><p>- Severe skin reactions including intense skin rash, hives, reddening of the skin over your whole body, severe itching, blistering, peeling and swelling of the skin, inflammation of mucous membranes (Stevens Johnson Syndrome) or other allergic reactions.</p><p>- Heart attack, abnormal heart beat.</p><p>- Inflamed pancreas which may cause severe abdominal and back pain accompanied with feeling very unwell.</p><p>The following very common side effect has been reported. If this causes you problems or if it lasts for more than one week, you should contact your doctor.</p><p>&nbsp;</p><p>Very common: may affect more than 1 in every 10 patients- Edema (fluid retention)</p><p>The following common side effects have been reported. If any of these cause you problems or if they last for more than one week, you should contact your doctor.</p><p>&nbsp;</p><p>Common: may affect less than 1 in every 10 patients</p><p>- Headache, dizziness, sleepiness (especially at the beginning of treatment)</p><p>- Palpitations (awareness of your heart beat), flushing.- Abdominal pain, feeling sick (nausea).</p><p>- Altered bowel habits, diarrhoea, constipation, indigestion.</p><p>- Tiredness, weakness.</p><p>- Visual disturbances, double vision.</p><p>- Muscle cramps.</p><p>- Ankle swelling.Other side effects that have been reported include the following list.</p><p>If any of these get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist</p><p>&nbsp;</p><p>.Uncommon: may affect less than 1 in every 100 patients</p><p>- Mood changes, anxiety, depression, sleeplessness</p><p>- Trembling, taste abnormalities, fainting</p><p>- Numbness or tingling sensation in your limbs, loss of pain sensation</p><p>- Ringing in the ears</p><p>- Low blood pressure</p><p>- Sneezing/running nose caused by inflammation of the lining of the nose (rhinitis)</p><p>- Cough</p><p>- Dry mouth, vomiting (being sick)</p><p>- Hair loss, increased sweating, itchy skin, red patches on skin, skin discolouration.</p><p>- Disorder in passing urine, increased need to urinate at night, increased number of times of passing urine.</p><p>- Inability to obtain an erection, discomfort or enlargement of the breasts in men.</p><p>- Pain, feeling unwell.</p><p>- Joint or muscle pain, back pain.</p><p>- Weight increase or decrease.</p><p>&nbsp;</p><p>Rare: may affect less than 1 in every 1,000 patients</p><p>&nbsp;</p><p>ConfusionVery rare: may affect less than 1 in every 10,000 patients</p><p>- Decreased numbers of white blood cells, decrease in blood platelets which may result in unusual bruising or easy bleeding.</p><p>- Excess sugar in blood (hyperglycaemia).</p><p>- A disorder of the nerves which can cause muscular weakness, tingling or numbness.</p><p>- Swelling of the gums.</p><p>- Abdominal bloating (gastritis).</p><p>- Abnormal liver function, inflammation of the liver (hepatitis), yellowing of the skin (jaundice), liver enzyme increase which may have an effect on some. medical tests.</p><p>- Increased muscle tension.</p><p>- Inflammation of blood vessels, often with skin rash.</p><p>- Sensitivity to light.</p><p>- Disorders combining rigidity, tremor, and/or movement disorders.</p><p>&nbsp;</p><p>Reporting of side effects</p><p>If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects you can help provide more information on the safety of this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Do not use this medicine after the expiry date which is stated on the pack after &lsquo;EXP&rsquo;. The expiry date refers to the last day of that month.Do not store above 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance in tablets is amlodipine (as besilate).</p><p>The other ingredients are Micro-crystalline cellulose, Dibasic calcium phosphate anhydrous, Sodium starch glycolate, Magnesium stearate, Colloidal silicon dioxide.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                White circular uncoated tablets available in Carton box containing three blisters each of 10 tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>BATTERJEE PHARMA</p><p>Street No.: 401, Road No.: 403,</p><p>Industrial Area-Phase-IV,</p><p>P.O. Box: 10667,</p><p>Jeddah-21443,</p><p>Kingdom of Saudi Arabia.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                06/2020
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>&nbsp;</p><p>أملوكارد &reg; یحتوي على المادة الفعالة أملودیبین الذي ینتمي إلى مجموعة من الأدویة تسمى محصرات قنوات الكالسیوم.</p><p>&nbsp;</p><p>یستخدم لعلاج:تارتفاع ضغط الدم أو نوع معین من ألم الصدر الذي یسمى بالذبحة الصدرية.</p><p>&nbsp;</p><p>&nbsp;</p><p>في المرضى الذین یعانون من ارتفاع ضغط الدم. یعمل ھذا الدواء عن طریق انبساط وتوسیع الأوعیة الدمویة، لذلك یمر ھذا الدم من خلالھا بسھولة أكبر. في المرضى الذین یعانون من الذبحة الصدریة یعمل من خلال تحسین تدفق الدم الى عضلة القلب بذلك تستقبل المزید من الأوكسجین ویتجنب حدوث الذبحة الصدریة. ھذا الدواء لا یوفر الإغاثة الفوریة من آلام في الصدر من الذبحة الصدریة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&nbsp;</p><p>قبل أن تتناول أملوكارد&reg;</p><p>لا تأخذ أملوكارد &reg;:</p><p>- إذا كنت تعاني من الحساسیة إلى أملودیبین، أو أي من المكونات الأخرى من ھذا الدواء المذكور في قسم ٦، أو من أي محصرات قنوات الكالسیوم الأخرى.- قد تكون ھذه الحساسیة على ھیئة حكة في الجلد، احمرار الجلد أو صعوبة في التنفس.</p><p>- إذا كان لدیك انخفاض شدید في ضغط الدم.</p><p>- إذا كنت تعاني من قصور في القلب بعد اصابتھ بأزمة قلبیة.</p><p>التحذیرات والاحتیاطات:</p><p>التحدث مع طبیبك أو الصیدلاني قبل أخذ أملوكارد&reg;.</p><p>یجب إبلاغ الطبیب إذا كان لدیك أو كان أي من الحالات التالیة:</p><p>- نوبة قلبیة.</p><p>- فشل القلب.</p><p>- أزمة ارتفاع ضغط الدم.</p><p>- امراض الكبد.</p><p>- من كبار السن ویحتاج الى زیادة الجرعة.</p><p>&nbsp;</p><p>الأطفال والمراھقین:</p><p>لم یدرس تأثیر أملوكارد&reg; على الأطفال الذین تقل أعمارھم عن ٦ سنوات وینبغي أن تستخدم فقط لارتفاع ضغط الدم لدى الأطفال والمراھقین من ٦ سنوات إلى ۱۷ سنة.</p><p>&nbsp;</p><p>أملوكارد&reg; و الأدویة الأخرى:قد یخفض ضغط الدم لدیك أكثر إذا كنت تأخذ بالفعل أدویة أخرى لعلاج ارتفاع ضغط الدم.</p><p>&nbsp;</p><p>أملوكارد&reg; مع الطعام والشراب:یجب عدم تناول عصیر الجریب فروت والجریب فروت مع أملوكارد&reg;.وذلك لأن الجریب فروت وعصیر جریب فروت یمكن أن یؤدي إلى زیادة في مستویات الدم من أملودیبین، و الذي یمكن أن یسبب زیادة غیر متوقعة في خفض ضغط الدم.</p><p>&nbsp;</p><p>الحمل والرضاعة الطبیعیة:لم تثبت سلامة أملودیبین في الحمل. إذا كنتي تعتقدي أنك قد تكوني حاملا، أو تخططین لذلك ، یجب أن تخبري طبیبك قبل أن تأخذي أملوكارد&reg;. لا یعرف ما إذا كان یتم تمریر أملودیبین في حلیب الثدي. إذا كنت ترضعین الرضاعة الطبیعیة یجب أن تخبرى طبیبك قبل أخذ أملوكارد&reg;.</p><p>&nbsp;</p><p>قیادة المركبات أو استخدام المعداتتناول أملوكارد&reg; قد یؤثر على قدرتك على قیادة المركبات أو استخدام المعدات. إذا كان تناول الأقراص یجعلك تشعر بالدوار أو التعب، أو الصداع، اتصل بطبیبك على الفور.أملوكارد&reg; یحتوي على أقل من ۱ ملیمول الصودیوم )۲۳ ملجم( للقرص الواحد. مما یعني أنھ ھو أساسا خالي من الصودیوم.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>دائما تناول ھذا الدواء تماما كما طبیبك أو الصیدلي قد قال لك. استشر طبیبك أو الصیدلي</p><p>إذا كنت غیر متأكدا:الجرعة الأولیة الموصى بھا ھي ٥ ملجم مرة واحدة یومیا. ویمكن زیادة الجرعة إلى ۱۰ ملجم مرة واحدة یومیا.</p><p>ھذا الدواء یمكن استخدامھ قبل أو بعد الطعام والمشروبات. یجب أن تأخذ ھذا الدواء في نفس الوقت كل یوم مع شربة ماء؛ لا تتناول أملوكارد&reg; مع عصیر الجریب فروت.</p><p>&nbsp;</p><p>&nbsp;</p><p>استخدام في الأطفال والمراهقين</p><p>بالنسبة للأطفال والمراھقین )٦-۱۷ سنة(، جرعة البدایة المعتادة الموصى بھا ھي ۲٫٥ ملجم یومیا أملوكارد&reg;. الحد الأقصى للجرعة الموصى بھا ھي ٥ ملجم یومیا یمكن تقسیمھا إلى نصفین لتوفیر جرعة ۲٫٥ ملجم.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جمیع الأدویة، یمكن لھذا الدواء أن یسبب آثارا جانبیة، على الرغم من أن الجمیع لا یحصل لھم ذلك . إذا كنت تواجھ أي من الآثار الجانبیة التالیة بعد تناول ھذا الدواء قم بزیارة الطبیب على الفور:</p><p>- الأزیز المفاجئ، ألم في الصدر، ضیق أو صعوبة في التنفس.</p><p>- تورم الجفون والوجھ أو الشفتین.</p><p>- تورم اللسان والحلق الذي یسبب صعوبة في التنفس.</p><p>- الحساسیة والتي تشمل الطفح الجلدي الشدید، احمرار الجلد على الجسم كلھ، وحكة شدیدة، تقشیر وتورم في الجلد، والتھاب الأغشیة المخاطیة )متلازمة ستیفنز جونسون( أو الحساسیة الأخرى غیر طبیعیة.</p><p>- نوبة قلبیة أو عدم انتظام ضربات القلب.</p><p>- التهاب البنكریاس مما قد یتسبب في آلام بالبطن وآلام الظھر مصحوبا بتوعك شدید. وقد تم الإبلاغ عن الآثار الجانبیة الأكثر شیوعا. إذا كان ھذا یسبب لك مشاكل أو إذا كان یستمر لأكثر من أسبوع واحد، یجب علیك الاتصال بطبیبك. قد تصیب تلك الآثار أكثر من ۱ كل ۱۰ مرضى</p><p>&nbsp;</p><p>الأكثر شیوعا:</p><p>- احتباس السوائل (الاستقساء)وقد تم الإبلاغ عن الآثار الجانبیة الشائعة التالیة. إذا كان أي من ھذه تسبب لك مشاكل أو إذا كانت تستمر لأكثر من أسبوع واحد، یجب علیك الاتصال بطبیبك. قد تصیب تلك الآثار أقل من ۱ كل ۱۰ مرضى</p><p>&nbsp;</p><p>المشتركة:</p><p>- الصداع، الدوخة، النعاس وخصوصا في بدایة العلاج.</p><p>- الخفقان.</p><p>- ألم في البطن والشعور بالغثیان.</p><p>- تغیرعادات الأمعاء، الإسھال، الإمساك وعسر الھضم.</p><p>- التعب والضعف.</p><p>- اضطرابات سمعیة والرؤیة المزدوجة.</p><p>- تشنجات العضلات.</p><p>- تورم في الكاحل.وتشمل الآثار الجانبیة الأخرى التي تم الإبلاغ عنھا في القائمة التالیة. إذا كان أي من ھذه تحصل خطیرة، أو إذا لاحظت أي آثار جانبیة غیر المذكورة في ھذه النشرة، یرجى إخبار الطبیب أو الصیدلاني. قد تصیب تلك الآثار ۱ من كل ۱۰۰ مریض</p><p>&nbsp;</p><p>شائعة:</p><p>- تقلبات في المزاج، والقلق، والاكتئاب، والأرق.</p><p>- الأرتجاف، تغیر الطعم والاغماء.</p><p>- التنمیل أو الإحساس بالوخز في الأطراف الخاص بك، وفقدان الإحساس بالألم.</p><p>- رنین في الأذنین.</p><p>- انخفاض ضغط الدم.</p><p>- العطس / سیلان الأنف الناجم عن التھاب الغشاء المبطن للأنف )التھاب الانف( سعال. - جفاف الفم والقيء.</p><p>- فقدان الشعر، زیادة التعرق، حكة في الجلد، البقع الحمراء على الجلد وتغیر لون الجلد.</p><p>- اضطراب في التبول، زیادة الحاجة للتبول لیلا وزیادة عدد مرات التبول. - عدم القدرة على الانتصاب، أو كبرحجم الثدي لدى الرجال.</p><p>- الألم والشعور بالإعیاء.</p><p>- آلام العضلات أو المفاصل وآلام الظھر.</p><p>- زیادة أو نقصان الوزن. یمكن أن تحدث إلى ۱ من كل ۱۰۰۰ مریض</p><p>&nbsp;</p><p>نادر:</p><p>- الارتباك.</p><p>&nbsp;</p><p>جدا نادرة:</p><p>ربما تصیب أقل من ۱ كل ۱۰،۰۰۰ مریض</p><p>- انخفاض خلایا الدم البیضاء، وانخفاض في الصفائح الدمویة والتي قد ینتج عنھا كدمات غیر عادیة أو سھولة النزیف.</p><p>- زیادة السكر في الدم (ارتفاع سكر الدم)</p><p>- خلل في الأعصاب الذي یمكن أن یسبب ضعف العضلات، ووخز أو تنمیل. - تورم اللثة. - الانتفاخ في المعدة.</p><p>- وظائف الكبد غیر طبیعیة، والتھاب الكبد، اصفرار الجلد (لیرقان) و زیادة انزیمات الكبد التي قد یكون لھا تأثیرعلى بعض الفحوصات الطبیة. -</p><p>الشد العضلي.</p><p>- التھاب الأوعیة الدمویة، في كثیر من الأحیان مع طفح جلدي.</p><p>- الحساسیة للضوء.</p><p>- اضطرابات في الحركة، تصلب العضلات أو الرعاش.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&nbsp;</p><p>حفظ ھذا الدواء بعید عن متناول الأطفال. لا تستخدم ھذا الدواء بعد تاریخ انتھاء الصلاحیة المدون على العلبة تاریخ انتھاء الصلاحیة یشیر إلى الیوم الأخیر من ذلك الشھر. لا تخزن فوق ۳۰ درجة مئویة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&nbsp;</p><p>المادة الفعالة في أملوكارد&reg;:ھي أملودیبین بیزیلات ٥ ملجم.المكونات الأخرى: سلیلوز دقیق التبلور، ثنائي القاعدة فوسفات الكالسیوم اللامائیة، نشا الصودیوم غلیكولات، ستیرات المغنیسیوم، ثاني أكسید السیلیكون الغروي.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>ما یبدو علیھ أملوكارد&reg; ومحتویات العبوة:أقراص دائریة بیضاء غیر مصقولة متاحة في علبة كرتون تحتوي على ثلاثة شرائط كل شریط بھ ۱۰ أقراص.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>بترجي فارما</p><p>الشارع رقم ٤۰۱ ،شارع رقم ٤۰۳ ،</p><p>منطقة المرحلة الرابعة الصناعیة،</p><p>ص. مربع: ۱۰٦٦۷ ،</p><p>جدة ۲۱٤٤۳ ،</p><p>المملكة العربیة السعودیة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            06/2020
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Amlocard® 5 mg tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each tablet contains amlodipine besilate equivalent to 5 mg amlodipine.
Excipients:
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Tablet.
Amlocard® 5 mg Tablets are white circular uncoated tablets .
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hypertension<br />Chronic stable angina pectoris<br />Vasospastic (Prinzmetal&#39;s) angina</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology<br />Adults<br />For both hypertension and angina the usual initial dose is 5 mg Amlocard&reg; once daily which may be increased to a maximum dose of 10 mg depending on the individual patient&#39;s response.<br />In hypertensive patients, Amlocard&reg; has been used in combination with a thiazide diuretic, alpha blocker, beta blocker, or an angiotensin converting enzyme inhibitor.<br />For angina, Amlocard&reg; may be used as mono therapy or in combination with other anti- anginal medicinal products in patients with angina that is refractory to nitrates and/or to adequate doses of beta blockers.<br />No dose adjustment of Amlocard&reg; is required upon concomitant administration of thiazide diuretics, beta blockers, and angiotensin converting enzyme inhibitors.<br />Special populations<br />Elderly patients<br />Amlocard&reg; used at similar doses in elderly or younger patients is equally well tolerated. Normal dosage regimens are recommended in the elderly, but increase of the dosage should take place with care (see sections 4.4 and 5.2).<br />Patients with hepatic impairment<br />Dosage recommendations have not been established in patients with mild to moderate hepatic impairment; therefore dose selection should be cautious and should start at the lower end of the dosing range (see sections 4.4 and 5.2). The pharmacokinetics of amlodipine have not been&nbsp;studied in severe hepatic impairment. Amlodipine should be initiated at the lowest dose and titrated slowly in patients with severe hepatic impairment.<br />Patients with renal impairment<br />Changes in amlodipine plasma concentrations are not correlated with degree of renal impairment, therefore the normal dosage is recommended. Amlodipine is not dialysable.<br />Pediatric population<br />Children and adolescents with hypertension from 6 years to 17 years of age.<br />The recommended antihypertensive oral dose in pediatric patients ages 6-17 years is 2.5 mg once daily as a starting dose, up titrated to 5 mg once daily if blood pressure goal is not achieved after 4 weeks. Doses in excess of 5 mg daily have not been studied in pediatric patients (see sections 5.1 and 5.2).<br />Children under 6 years old<br />No data are available.<br />Method of administration<br />Tablet for oral administration.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Amlodipine is contraindicated in patients with:
hypersensitivity to dihydropyridine derivatives, amlodipine or to any of the excipients listed in section 6.1.
severe hypotension.
shock (including cardiogenic shock).
obstruction of the outflow tract of the left ventricle (e.g., high grade aortic stenosis).
haemodynamically unstable heart failure after acute myocardial infarction.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The safety and efficacy of amlodipine in hypertensive crisis has not been established.<br />Patients with cardiac failure<br />Patients with heart failure should be treated with caution. In a long term, placebo controlled study in patients with severe heart failure (NYHA class III and IV) the reported incidence of pulmonary edema was higher in the amlodipine treated group than in the placebo group (see section 5.1). Calcium channel blockers, including amlodipine, should be used with caution in patients with congestive heart failure, as they may increase the risk of future cardiovascular events and mortality.<br />Patients with hepatic impairment<br />The half-life of amlodipine is prolonged and AUC values are higher in patients with impaired liver function; Dosage recommendations have not been established. Amlodipine should therefore be initiated at the lower end of the dosing range and caution should be used, both on initial treatment and when increasing the dose. Slow dose titration and careful monitoring may be required in patients with severe hepatic impairment.</p><p>Elderly patients<br />In the elderly increase of the dosage should take place with care (see sections 4.2 and 5.2).<br />Patients with renal impairment<br />Amlodipine may be used in such patients at normal doses. Changes in amlodipine plasma concentrations are not correlated with degree of renal impairment. Amlodipine is not dialysable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Effects of other medicinal products on amlodipine<br />CYP3A4 inhibitors<br />Concomitant use of amlodipine with strong or moderate CYP3A4 inhibitors (protease inhibitors, azole antifungals, macrolides like erythromycin or clarithromycin, verapamil or diltiazem) may give rise to significant increase in amlodipine exposure resulting in an increased risk of hypotension. The clinical translation of these PK variations may be more pronounced in the elderly. Clinical monitoring and dose adjustment may thus be required.<br />CYP3A4 inducers<br />There is no data available regarding the effect of CYP3A4 inducers on amlodipine. The concomitant use of CYP3A4 inducers (e.g., rifampicin, hypericum perforatum) may give a lower plasma concentration of amlodipine. Amlodipine should be used with caution together with CYP3A4 inducers.<br />Administration of amlodipine with grapefruit or grapefruit juice is not recommended as bioavailability may be increased in some patients resulting in increased blood pressure lowering effects.<br />Dantrolene (infusion)<br />In animals, lethal ventricular fibrillation and cardiovascular collapse are observed in association with hyperkalemia after administration of verapamil and intravenous dantrolene. Due to risk of hyperkalemia, it is recommended that the co-administration of calcium channel blockers such as amlodipine be avoided in patients susceptible to malignant hyperthermia and in the management of malignant hyperthermia.<br />Effects of amlodipine on other medicinal products<br />The blood pressure lowering effects of amlodipine adds to the blood pressure lowering effects of other medicinal products with antihypertensive properties.<br />Tacrolimus<br />There is a risk of increased tacrolimus blood levels when co-administered with amlodipine but the pharmacokinetic mechanism of this interaction is not fully understood. In order to avoid toxicity of tacrolimus, administration of amlodipine in a patient treated with tacrolimus requires&nbsp;monitoring of tacrolimus blood levels and dose adjustment of tacrolimus when appropriate.</p><p>Cyclosporine<br />No drug interaction studies have been conducted with cyclosporine and amlodipine in healthy volunteers or other populations with the exception of renal transplant patients, where variable trough concentration increases (average 0% 40%) of cyclosporine were observed. Consideration should be given for monitoring cyclosporine levels in renal transplant patients on amlodipine, and cyclosporine dose reductions should be made as necessary.<br />Simvastatin<br />Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin alone. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.<br />In clinical interaction studies, amlodipine did not affect the pharmacokinetics of atorvastatin, digoxin or warfarin.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />The safety of amlodipine in human pregnancy has not been established.<br />In animal studies, reproductive toxicity was observed at high doses (see section 5.3).<br />Use in pregnancy is only recommended when there is no safer alternative and when the disease itself carries greater risk for the mother and fetus.<br />Breastfeeding<br />It is not known whether amlodipine is excreted in breast milk. A decision on whether to continue/discontinue breastfeeding or to continue/discontinue therapy with amlodipine should be made taking into account the benefit of breastfeeding to the child and the benefit of amlodipine therapy to the mother.<br />Fertility<br />Reversible biochemical changes in the head of spermatozoa have been reported in some patients treated by calcium channel blockers. Clinical data are insufficient regarding the potential effect of amlodipine on fertility. In one rat study, adverse effects were found on male fertility (see section 5.3).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Amlodipine can have minor or moderate influence on the ability to drive and use machines. If patients taking amlodipine suffer from dizziness, headache, fatigue or nausea the ability to react may be impaired. Caution is recommended especially at the start of treatment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Summary of the safety profile<br />The most commonly reported adverse reactions during treatment are somnolence, dizziness, headache, palpitations, flushing, abdominal pain, nausea, ankle swelling, edema and fatigue.<br />Tabulated list of adverse reactions</p><p>The following adverse reactions have been observed and reported during treatment with amlodipine with the following frequencies: Very common (&ge;1/10); common (&ge;1/100 to &lt;1/10); uncommon (&ge;1/1,000 to &lt;1/100); rare (&ge;1/10,000 to &lt;1/1,000); very rare (&lt;1/10,000).<br />Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.<br />System organ class<br />Frequency<br />Adverse reactions<br />Blood and lymphatic system<br />disorders<br />Very rare<br />Leukocytopenia,thrombocytopenia<br />Immune system disorders<br />Very rare<br />Allergic reactions<br />Metabolism and nutrition disorders<br />Very rare<br />Hyperglycaemia<br />Psychiatric disorders<br />Uncommon<br />Rare<br />Depression, mood changes (including anxiety),<br />insomnia<br />Confusion<br />Nervous system disorders<br />Common<br />Uncommon<br />Very rare<br />Somnolence, dizziness, headache (especially<br />at the beginning of the treatment)<br />Tremor, dysgeusia, syncope, hypoaesthesia,<br />paraesthesia<br />Hypertonia, peripheral neuropathy<br />Eye disorders<br />Common<br />Visual disturbance (including diplopia)<br />Cardiac disorders<br />Common<br />Uncommon<br />Very rare<br />Palpitations<br />Arrhythmia (including bradycardia, ventricular<br />tachycardia and atrial fibrillation)<br />Myocardial infarction<br />Vascular disorders<br />Common<br />Uncommon<br />Very rare<br />Flushing<br />Hypotension<br />Vasculitis<br />Respiratory, thoracic and mediastinal<br />Common<br />Dyspnoea</p><p>disorders<br />Uncommon<br />Cough, rhinitis<br />Gastrointestinal disorders<br />Common<br />Uncommon<br />Very rare<br />Abdominal pain, nausea, dyspepsia, altered<br />bowel habits (including diarrhoea and<br />constipation(<br />Vomiting, dry mouth<br />Pancreatitis, gastritis, gingival hyperplasia<br />Hepato-biliary disorders<br />Very rare<br />Hepatitis, jaundice, hepatic enzyme increased<br />Skin and subcutaneous tissue<br />disorders<br />Uncommon<br />Very rare<br />Alopecia, purpura, skin discolouration,<br />hyperhidrosis, pruritus, rash, exanthema,<br />urticarial<br />Angioedema, erythema multiforme, exfoliative<br />dermatitis, Stevens-Johnson<br />syndrome,<br />Quincke edema, photosensitivity<br />Musculoskeletal and connective<br />tissue disorders<br />Common<br />Uncommon<br />Ankle swelling, muscle cramps<br />Arthralgia, myalgia, back pain</p><p>Renal and urinary disorders<br />Uncommon<br />Micturition disorder, nocturia, increased urinary<br />frequency<br />Reproductive system and breast<br />disorders<br />Uncommon<br />Impotence, gynaecomastia<br />General disorders and administration<br />site conditions<br />Very common<br />Common<br />Uncommon<br />Edema<br />Fatigue, asthenia<br />Chest pain, pain, malaise<br />Investigations<br />Uncommon<br />Weight increased, weight decreased<br />*mostly consistent with cholestasis</p><p>Exceptional cases of extrapyramidal syndrome have been reported.<br />Reporting of suspected adverse reactions<br />Reporting suspected adverse reactions after authorization of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions .</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In humans experience with intentional overdose is limited.<br />Symptoms<br />Available data suggest that gross over dosage could result in excessive peripheral vasodilatation and possibly reflex tachycardia. Marked and probably prolonged systemic hypotension up to and including shock with fatal outcome have been reported.<br />Treatment<br />Clinically significant hypotension due to amlodipine over dosage calls for active cardiovascular support including frequent monitoring of cardiac and respiratory function, elevation of extremities and attention to circulating fluid volume and urine output.<br />A vasoconstrictor may be helpful in restoring vascular tone and blood pressure, provided that there is no<br />contraindication to its use. Intravenous calcium gluconate may be beneficial in reversing the effects of calcium channel blockade.<br />Gastric lavage may be worthwhile in some cases. In healthy volunteers the use of charcoal up to 2 hours after administration of amlodipine 10 mg has been shown to reduce the absorption rate of amlodipine.<br />Since amlodipine is highly protein bound, dialysis is not likely to be of benefit.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Calcium channel blockers, selective calcium channel blockers with mainly vascular effects.<br />ATC Code: C08CA01.<br />Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle.</p><p>The mechanism of the antihypertensive action of amlodipine is due to a direct relaxant effect on vascular smooth muscle. The precise mechanism by which amlodipine relieves angina has not been fully determined but amlodipine reduces total ischemic burden by the following two actions:<br />1) Amlodipine dilates peripheral arterioles and thus, reduces the total peripheral resistance (afterload) against which the heart works. Since the heart rate remains stable, this unloading of the heart reduces myocardial energy consumption and oxygen requirements.<br />2) The mechanism of action of amlodipine also probably involves dilatation of the main coronary arteries and coronary arterioles, both in normal and ischemic regions. This dilatation increases myocardial oxygen delivery in patients with coronary artery spasm (Prinzmetal&#39;s or variant angina).<br />In patients with hypertension, once daily dosing provides clinically significant reductions of blood pressure in both the supine and standing positions throughout the 24 hour interval. Due to the slow onset of action, acute hypotension is not a feature of amlodipine administration.<br />In patients with angina, once daily administration of amlodipine increases total exercise time, time to angina onset, and time to 1 mm ST segment depression, and decreases both angina attack frequency and glyceryl trinitrate tablet consumption.<br />Amlodipine has not been associated with any adverse metabolic effects or changes in plasma lipids and is suitable for use in patients with asthma, diabetes, and gout.<br />Use in patients with coronary artery disease (CAD)<br />The effectiveness of amlodipine in preventing clinical events in patients with coronary artery disease (CAD) has been evaluated in an independent, multicenter, randomized, double blind, placebo- controlled study of 1997 patients;<br />Comparison of Amlodipine vs. Enalapril to Limit Occurrences of Thrombosis (CAMELOT). Of these patients, 663 were treated with amlodipine 5-10 mg, 673 patients were treated with enalapril 10-20 mg, and 655 patients were treated with placebo, in addition to standard care of statins, beta blockers, diuretics and aspirin, for 2 years. The key efficacy results are presented in&nbsp;The results indicate that amlodipine treatment was associated with fewer hospitalizations for angina and revascularization procedures in patients with CAD.</p><p>Use in patients with heart failure<br />Hemodynamic studies and exercise based controlled clinical trials in NYHA Class IIIV heart failure patients have shown that Amlocard&reg; did not lead to clinical deterioration as measured by exercise tolerance, left ventricular ejection fraction and clinical symptomatology.<br />A placebo controlled study (PRAISE) designed to evaluate patients in NYHA Class IIIIV heart failure receiving digoxin, diuretics and ACE inhibitors has shown that Amlocard&reg; did not lead to an increase in risk of mortality or combined mortality and morbidity with heart failure.<br />In a follow up, long term, placebo controlled study (PRAISE2) of Amlocard&reg; in patients with NYHA III and IV heart failure without clinical symptoms or objective findings suggestive or underlying ischemic disease, on stable doses of ACE inhibitors, digitalis, and diuretics, Amlocard&reg; had no effect on total cardiovascular mortality. In this same population Amlocard&reg; was associated with increased reports of pulmonary edema.<br />Treatment to prevent heart attack trial (ALLHAT)<br />A randomized double-blind morbidity -mortality study called the Antihypertensive and Lipid-Lowering<br />Treatment to prevent Heart Attack Trial (ALLHAT) was performed to compare newer drug therapies: amlodipine 2.5-10 mg/d (calcium channel blocker) or lisinopril 10-40 mg/d (ACEinhibitor) as first line therapies to that of the thiazide diuretic, chlorthalidone 12.5-25 mg/d in mild to moderate hypertension.<br />A total of 33,357 hypertensive patients aged 55 or older were randomized and followed for a mean of 4.9 years. The patients had at least one additional CHD risk factor, including: previous myocardial infarction or stroke (&gt; 6 months prior to enrollment) or documentation of other atherosclerotic CVD (overall 51.5%), type 2 diabetes (36.1%), HDLC&lt; 35 mg/dL (11.6%), left ventricular hypertrophy diagnosed by electrocardiogram or echocardiography (20.9%), current cigarette smoking (21.9%).</p><p>The primary endpoint was a composite of fatal CHD or nonfatal myocardial infarction. There was no significant difference in the primary endpoint between amlodipine -based therapy and chlorthalidone -based therapy: RR 0.98 95% CI (0.901.07) p=0.65. Among secondary endpoints, the incidence of heart failure (component of a composite combined cardiovascular endpoint) was significantly higher in the amlodipine group as compared to the chlorthalidone group (10.2% vs. 7.7%, RR 1.38, 95% CI [1.251.52]<br />p&lt;0.001). However, there was no significant difference in all cause mortality between amlodipine-based therapy and chlorthalidone-based therapy. RR 0.96 95% CI [0.891.02]p=0.20.<br />Use in children (aged 6 years and older)<br />In a study involving 268 children aged 6-17 years with predominantly secondary hypertension, comparison of a 2.5 mg dose, and 5.0 mg dose of amlodipine with placebo, showed that both doses reduced Systolic Blood Pressure significantly more than placebo. The difference between the two doses was not statistically significant.<br />The long-term effects of amlodipine on growth, puberty and general development have not been studied. The long-term efficacy of amlodipine on therapy in childhood to reduce cardiovascular morbidity and mortality in adulthood has also not been established.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption, distribution, plasma protein binding: After oral administration of therapeutic doses, amlodipine is well absorbed with peak blood levels between 6-12 hours post dose. Absolute bioavailability has been estimated to be between 64 and 80%. The volume of distribution is approximately 21 l/kg. In vitro studies have shown that approximately 97.5% of circulating amlodipine is bound to plasma proteins.<br />The bioavailability of amlodipine is not affected by food intake.<br />Biotransformation/elimination<br />The terminal plasma elimination half- life is about 35-50 hours and is consistent with once daily dosing. Amlodipine is extensively metabolized by the liver to inactive metabolites with 10% of the parent compound and 60% of metabolites excreted in the urine.<br />Hepatic impairment<br />Very limited clinical data are available regarding amlodipine administration in patients with hepatic impairment. Patients with hepatic insufficiency have decreased clearance of amlodipine resulting in a longer half-life and an increase in AUC of approximately 40-60%.<br />Elderly population<br />The time to reach peak plasma concentrations of amlodipine is similar in elderly and younger subjects. Amlodipine clearance tends to be decreased with resulting increases in AUC and elimination half-life in elderly patients. Increases in AUC and elimination half-lifein patients with congestive heart failure were as expected for the patient age group studied.<br />Paediatric population<br />A population PK study has been conducted in 74 hypertensive children aged from 1 to 17 years (with 34 patients aged 6 to 12 years and 28 patients aged 13 to 17 years) receiving amlodipine&nbsp;between 1.25 and 20 mg given either once or twice daily. In children 6 to 12 years and in adolescents 13-17 years of age the typical oral clearance (CL/F) was 22.5 and 27.4 L/hr respectively in males and 16.4 and 21.3 L/hr respectively in females. Large variability in exposure between individuals was observed. Data reported in children below 6 years is limited.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Reproductive toxicology<br />Reproductive studies in rats and mice have shown delayed date of delivery, prolonged duration of labour and decreased pup survival at dosages approximately 50 times greater than the maximum recommended dosage for humans based on mg/kg.<br />Impairment of fertility<br />There was no effect on the fertility of rats treated with amlodipine (males for 64 days and females 14 days prior to mating) at doses up to 10 mg/kg/day (8 times* the maximum recommended human dose of 10 mg on a mg/m basis).<br />In another rat study in which male rats were treated with amlodipine besilate for 30 days at a dose comparable with the human dose based on mg/kg, decreased plasma follicle stimulating hormone and testosterone were found as well as decreases in sperm density and in the number of mature spermatids and Sertoli cells.<br />Carcinogenesis, mutagenesis<br />Rats and mice treated with amlodipine in the diet for two years, at concentrations calculated to provide daily dosage levels of 0.5, 1.25, and 2.5 mg/kg/day showed no evidence of carcinogenicity. The highest dose (for mice, similar to, and for rats twice* the maximum recommended clinical dose of 10 mg on a mg/m basis) was close to the maximum tolerated dose for mice but not for rats.<br />Mutagenicity studies revealed no drug related effects at either the gene or chromosome levels.<br />*Based on patient weight of 50 kg</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Microcrystalline cellulose, Dibasic calcium phosphate anhydrous, Sodium starch glycolate, Magnesium stearate, Colloidal silicon dioxide.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Carton box containing three blisters each of 10 tablets.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                BATTERJEE PHARMA
Street No.: 401, Road No.: 403,
Industrial Area-Phase-IV,
P.O. Box: 10667, Jeddah-21443,
Kingdom of Saudi Arabia
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                October 2016
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>